Pot Stocks Tanked


By Kristen Barrett, Banyan Hill Publishing, Tuesday, November 19

Story Highlights

  • Major Canadian cannabis producers, including Cronos Group, MediPharm Labs and OrganiGram, announced third-quarter earnings this week.
  • Stock moves following the reports were surprising.
  • Pot stock guru Anthony Planas updated his exclusive Green Flag Index, which gives you the advantage you need in this sector.

This week, Canadian cannabis companies reported third-quarter earnings. The results — and stocks’ reactions — were surprising.

Here in the office, when any of us have a question about pot stocks, Anthony Planas is the first person we ask.

Anthony is so tuned in to the sector, he created an index to help us identify the best (and worst) marijuana companies at any given moment. Read on for the latest update on the index.

He also records a free YouTube video every week — even a couple of weeks ago, when he was on vacation in Hawaii! — where he discusses breaking news in the industry.

If you missed Anthony’s free Marijuana Markets video on Thursday, check it out now!

He covered earnings reports from Canadian cannabis producers including Cronos, the world’s largest cannabis company.

These heavy hitters’ reports are important for cannabis investors because they tell us the direction we can expect the sector to take.

You can see the news he covered in the snapshots below — but be sure to watch Anthony’s video for his take on all three companies’ earnings.

Now, I want to share more about Anthony’s Green Flag Index.

No other company in the world has this index. If you’re interested in profiting from the pot market, you need to pay attention. It’s the key to getting far ahead of the crowd.

What the Green Flag Index Tells Us

Anthony dubbed his proprietary metric the Green Flag Index.

It measures what we’d pay for a company based on how much product it sells — measured in kilograms produced and average price per gram.

By knowing the value of each company — which is the cheapest and which is the most expensive — we go a long way toward identifying the best investments.

The other crucial piece is Anthony’s top-notch analysis. He blended each company’s current and future production to create this index.

The higher the rating, the more you pay for shares of that producer.

After this latest batch of earnings, I asked Anthony to give us an update. (You can see his update, from October 17 here.)

Here are the latest numbers, ordered from least expensive to most.

I’ve been following Anthony’s index long enough to know that a stock isn’t a buy just because it’s among the least expensive — and the most expensive stocks are sometimes priced that way because they’re worth it.

When I asked Anthony what he makes of these numbers, here’s what he told me:

Cronos Group holds on to the top spot for most expensive producer. While overall sales grew, the price per gram sank to near industry lows. Shares are buoyed thanks to its partnership with the tobacco-maker Altria Group. But continued weak performance threatens this relationship.

OrganiGram Holdings and Hexo Corp. are the cheapest after big sell-offs from disappointing earnings. Neither has the support from a major alcohol or tobacco partner to support operations through weak sales.

Aphria Inc. is in a good position to drive revenue growth and see positive earnings. It trades at a discount to the average of its peers.

If you’re new to Winning Investor Daily or to cannabis investing, just know that the sector’s taken a massive hit this fall.

This $20 Stock May Be Wall Street’s Best-Kept Secret [sponsor]

This new tech company is on track to dominate both broadband and 5G wireless across an entire continent. However, due to an unusual situation, few outside of Wall Street are even aware this stock exists. Those who know about it and act now could reap a fortune. Click here for details.



 
 

Pot Stocks Tanked | www.RediNews.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video.